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The ability of human immunodeficiency virus type 1 (HIV-1) to fuse its membrane with the membrane of the target cell
is a function of a 23-amino-acid amino-terminal segment of the gp41 subunit of the envelope glycoprotein complex, known
as the fusion peptide. The sequence of the fusion peptide is highly conserved among different variants of HIV-1 and is also
very similar to that of HIV-2 and SIV. The fusion peptide is very hydrophobic and has a high content of glycine and alanine
residues. Representation of the fusion peptide of HIV-1 as an a-helix predicts that most glycine residues would be found
on one face of the a-helix. To assess the importance of the glycine residues for the fusogenic activity of the envelope
glycoprotein complex, we mutagenized each glycine residue in the fusion peptide individually to a valine residue. The mutant
envelope constructs were tested for their ability to induce syncytia (cell/cell fusion) and to mediate infection (virus/cell
fusion) of CD4-positive cells. The results of our analyses show that two glycine residues (G10 and G13) located within the
sequence FLGFLG in the middle of the fusion peptide are critical for syncytium formation and for the establishment of a
productive infection, whereas other glycine residues (G3, G5, and G20) are more permissive to substitutions. Mutation of
each of the two phenylalanines (F8 and F11) of the FLGFLG sequence to valine also decreased fusion, although to a lesser
extent than mutation of G10 and G13. These observations demonstrate that G10 and G13 are critical elements of the fusion
peptide and suggest that, in addition to hydrophobicity, the exact amino acid composition and structure of the fusion peptide
are critical for function. q 1996 Academic Press, Inc.
INTRODUCTION The fusogenic activity of gp41 resides within a discrete
amino-terminal polypeptide segment known as the fu-Infection of cells by human immunodeficiency virus
sion peptide (Gallaher, 1987; Felser et al., 1989; Freedtype 1 (HIV-1) requires fusion of the viral envelope with
et al., 1990). The HIV-1 fusion peptide is composed ofthe plasma membrane of the host cell (Stein et al., 1987).
about 23 amino acid residues with a high average hydro-The ability of HIV-1 to fuse with target membranes is
phobicity (Fig. 1). A salient feature of the HIV-1 fusiona property of the viral envelope glycoprotein complex,
peptide is its high content in amino acid residues withgp120–gp41 (Lifson et al., 1986; Sodroski et al., 1986;
no side chains, such as glycine, or small side chains,reviewed by Freed and Martin, 1995). The complex is
such as alanine (11 glycine and alanine residues of 23synthesized as a precursor, gp160, that must undergo
total residues, Fig. 1). The sequence of the fusion peptideproteolytic cleavage to gp120–gp41 in order to be com-
is extremely conserved among different isolates of HIV-petent for fusion (McCune et al., 1988; Freed et al., 1989).
1 (Myers, 1988) and is also highly homologous to se-Two other regions of the gp120 protein have been shown
quences found in other immunodeficiency viruses suchto be important for membrane fusion, the V3 loop (Rusche
as HIV-2 and SIV (Bosch et al., 1989; see Table 2). Theet al., 1988) and the V1/V2 region (Sullivan et al., 1993).
high degree of conservation of this sequence suggestsThe gp120 component of the complex binds to CD4 on
selective pressure to maintain not only the hydropho-the target cell (Dalgleish et al., 1984, Klatzmann et al.,
bicity of the peptide but also its exact primary structure.1984), after which gp41 induces fusion of the viral and
The structure of fusion peptides, including that of HIV-host cell membranes (Kowalski et al., 1987). Membranes
1, has been the subject of intense interest in recent yearsof human cells may also have a second receptor or a
(for reviews, see White, 1990, 1992). The prevailing view,particular lipid composition that allows for fusion, since
derived from theoretical analyses and experimental data,human CD4 expressed on murine cells is not sufficient
is that the active species of most fusion peptides adoptsfor infection by HIV-1 (Maddon et al., 1986; Broder et al.,
an a-helical configuration in lipid environments (Bras-1993).
seur et al., 1988; Rafalski et al., 1990; Martin et al., 1991).
In such a structure, most of the bulky hydrophobic resi-1 To whom correspondence and reprint requests should be ad-
dues would be located on one face of the helix, whereasdressed at Cell Biology and Metabolism Branch, NICHD, Building 18T,
residues with small side chains would be located onRoom 101, National Institutes of Health, Bethesda, MD 20892. Fax:
(301) 402-0078. E-mail: juan@helix.nih.gov. the opposite face (Bosch et al., 1989; White, 1992). This
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characteristic distribution of side chains has led to the tured as untransfected HeLa cells. The pNL4-3 plasmid
(Adachi et al., 1986), encoding the full-length HIV-1 ge-definition of such structures as sided (or lopsided) a-
helices (White, 1990; Blobel et al., 1992). While this model nome, and the pNLA1 plasmid (Willey et al., 1992), which
encodes a gag–pol deleted HIV-1 genome, were pro-is conceptually attractive, the possibility that fusion pep-
tides are not a-helices but b-structures has also been vided by Ronald Willey (NIAID, NIH).
raised in the literature (Gallaher et al., 1992; Epand et al.,
DNA mutagenesis and cloning1992; Nieva et al., 1994). Distinguishing between these
different models for HIV-1 will ultimately require solving
The NheI–BamHI fragment of pNLA1, containing the
the three-dimensional structure of the active form of the
env coding sequence, was subcloned into the NheI and
fusion peptide.
BamHI sites of pSP64 (Promega, Madison, WI), and mu-
When applied to HIV-1, the hypothesis that the fusion
tants were constructed using the Transformer site-di-
peptide has an a-helical structure would result in most
rected mutagenesis kit (Clontech, Palo Alto, CA). Mutants
glycine residues being located on one face of the helix
were identified by DNA sequencing and then subcloned
while most bulky hydrophobic residues would be con-
back into the NheI–BamHI sites of pNLA1. These plas-
centrated on another face (Fig. 1) (White, 1990). This
mids were then used for transfection into HeLa cells to
alignment of glycine residues is reminiscent of a ‘‘glycine
assess their ability to be expressed and processed and
strip’’ described within the transmembrane domains of
to form syncytia. For testing the effect of these mutations
class II MHC molecules (Cosson and Bonifacino, 1992).
on infectivity, mutant envelope coding sequences
The glycine residues are conserved among numerous
(BamHI– SalI fragments) were subcloned from pNLA1
variants of HIV-1, suggesting that they might serve a
into BamHI–SalI-digested pNL4-3.
critical function in viral propagation.
To test whether the conserved glycine residues play Antibodies
a role in the fusion process, we have conducted a sys-
Antibodies to gp160/gp120 (human HIV immune globu-tematic mutational analysis of glycine residues within
lin from Dr. Alfred Prince) were obtained from the NIHthe HIV-1 fusion peptide. Glycine residues, which have
AIDS Research and Reference Reagent Program, Divi-no side chains, were individually substituted by valine
sion of AIDS, NIAID. The mouse monoclonal antibodyresidues, which have bulky hydrophobic side chains.
D19, to gp120 (Earl et al., 1994), was the gift of PatriciaWhile these mutations altered the size of specific amino
Earl (NIAID, NIH).acid side chains, they preserved the overall hydrophobic
character of the fusion peptide. Mutants were analyzed
Cell culture and fusion assaysfor the synthesis and processing of gp160, syncytium
formation, and infectivity. Analysis of the biological prop-
Transfections were done using the calcium phosphate
erties of such mutants showed that two of the glycine
precipitation method (Graham and van der Eb, 1973) us-
residues (G10 and G13), contained within the conserved
ing 20 mg plasmid DNA per 3 1 106 cells. At 15 to 24 hr
sequence FLGFLG, are critical for the fusogenic activity
after transfection, cells were trypsinized and an aliquot
of the envelope glycoprotein complex. This sequence
was mixed with an equal number of CD4-expressing
lies in the middle of the fusion peptide. Other glycine
HeLa cells (Maddon et al., 1986) for the syncytium forma-
residues located toward both ends of the fusion peptide
tion assay, and another aliquot plated separately for
were found to be less important for fusion. The conserved
pulse/chase labeling experiments. Twenty-four hours
phenylalanine residues of the FLGFLG sequence (F8 and
later, the cells were stained in a solution of 5 g of methyl-
F11) were also important for optimal fusogenic activity,
ene blue per liter and 1.7 g of pararosaniline per liter in
although their mutation to valine had less of an effect
methanol and were scored for syncytia. Syncytia (having
than mutation of G10 and G13. These observations support
greater than four nuclei) were counted microscopically
the notion that specific glycine residues are critical ele-
from 10 different fields on the plate; the same number of
ments of fusion peptides and provide an explanation for
areas were counted for cells transfected with the wild-
the strict conservation of such residues among primate
type and the mutant glycoprotein constructs. The number
lentiviruses.
of syncytia were corrected for the level of expression as




Metabolic labeling and immunoprecipitation
HeLa cells were cultured in Dulbecco’s modified Ea-
gle’s medium (DMEM) containing 10% fetal bovine serum Transfected HeLa cells were scraped from flasks ei-
ther 24 or 48 hr posttransfection, washed, and preincu-(FBS) and 0.09 mg/ml gentamicin. HeLa cells transfected
with human CD4 (HeLa-T4) (Maddon et al., 1986) were bated in methionine-free DMEM for 10 min. Cells were
pulse-labeled for 30 min with [35S]methionine (Tran 35Speriodically selected in 1 mg/ml geneticin for 2 to 3 days
to maintain expression of CD4, but otherwise were cul- Label, ICN Radiochemicals, Irvine, CA) in methionine-
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free DMEM/10% FBS and, in some experiments, chased
for various periods in complete medium. After incubation,
cells were collected by centrifugation and frozen at0707.
Cell pellets were thawed and lysed in 1 ml of 1% (w/v)
Triton X-100, 50 mM Tris–HCl, pH 7.4, 300 mM NaCl, 10
mg/ml leupeptin, 0.1 mM phenylmethylsulfonyl fluoride,
and 1.8 mg/ml iodoacetamide, incubated at 47 for 15
min, and centrifuged at 14,000 rpm for 15 min to remove
insoluble material. Culture supernatants were cleared by
centrifugation at 2000 rpm for 10 min at 47. The cell
lysates and cleared supernatants were immunoprecipi-
tated with anti-gp160/120 polyclonal antibodies bound to
protein A–Sepharose and washed with 0.1% (w/v) Triton
X-100, 50 mM Tris–HCl, pH 7.4, 300 mM NaCl. Immuno-
precipitated proteins were boiled for 5 min in SDS sam- FIG. 1. Amino acid sequence of HIV-1 fusion peptide and schematic
ple buffer with 0.5 M dithiothreitol and analyzed on 10% representation of the sequence as an a-helix. Numbers correspond to
positions counted from the amino terminus of gp41 (NL4-3 variant).SDS–polyacrylamide gels. Gels were enhanced with 1
The carboxy-terminal boundary of the fusion peptide is not well definedM sodium salicylate, dried, and fluorographed. Quantita-
and therefore the end of the sequence was chosen arbitrarily. Glycinetion of expression was performed using a Molecular Dy-
residues are underlined in the linear sequence and highlighted in black
namics ImageQuant series 400 system (Sunnyvale, CA). in the a-helical representation.
The ability of the newly synthesized gp160 glycoproteins
to bind to CD4 was determined by precipitation of meta-
bolically pulse-labeled cells with a CD4–IgG construct RESULTS
(Lasky et al., 1987) bound to protein A.
Mutagenesis of the HIV-1 fusion peptide
FACS analysis The HIV-1 envelope glycoprotein complex is synthe-
sized as a precursor, gp160, that is subsequently cleaved
HeLa cells were transiently transfected with pNLA1 into two proteins, gp120 and gp41. The fusion peptide of
plasmids encoding the wild-type, G10V, or G13V enve- HIV-1 (Fig. 1) is located at the amino terminus of the
lope glycoproteins. At 40 –48 hr after transfection, cells gp41 subunit of the complex (Felser et al., 1989). Oligonu-
were rinsed with PBS and treated with 4 ml of 10 mM cleotide-directed mutagenesis of the env gene was per-
EDTA in PBS at 377 until cells lifted off of the culture formed to introduce targeted mutations within the region
flask. After dilution with 10 ml of medium, the cells were of the fusion peptide. Glycine residues at positions 3, 5,
pelleted and resuspended in cold 2% FBS in PBS (FACS 10, 13, 16, and 20 from the gp41 amino terminus were
buffer). Cells were counted and aliquoted into 1 1 106 individually mutated to valines (Fig. 2). In another mutant
cells per sample. Cells were washed once in FACS buffer (G10VG13V), both glycines at positions 10 and 13 were
and then resuspended in 100 ml of the same buffer con- mutated to valines (Fig. 2). Two conserved phenylalanine
taining 5 mg of mouse monoclonal antibody to gp120 residues at positions 8 and 11 were also individually
(D19; Earl et al., 1994). After a 1-hr incubation, the cells replaced by valine residues (Fig. 2). DNA fragments con-
were washed twice in cold FACS buffer and then resus- taining these mutations were subcloned into the expres-
pended in FACS buffer containing fluorescein-conju- sion plasmids pNLA1, which contains the HIV-1 genome
gated goat anti-mouse immunoglobulins (Jackson Immu- with a deletion in the gag–pol region (Willey et al., 1992),
noResearch, West Grove, PA) and incubated on ice for and pNL4-3, which contains the complete HIV-1 genome
1 hr. Cells were again washed twice with cold FACS (Adachi et al., 1986).
buffer. FACS analysis was performed on a Becton–Dick-
inson FACScan (San Jose, CA). Biosynthesis and processing of wild-type and mutant
env gene products
Infectivity assays
An essential prerequisite to study the role of specific
residues in the fusogenic activity of the envelope glyco-Envelope mutants were subcloned into the infectious
clone pNL4-3. The T-cell line CEM (12D-7) was proteins is that the mutations do not alter other biological
properties of the molecules, such as their biosynthesistransfected with 5 mg of plasmid DNA by the DEAE –
Dextran method as previously described (Freed and Mar- and processing. To evaluate the effect of mutations on
the biogenesis of the envelope glycoproteins, pNLA1tin, 1994). Every 2 days, the cells were split 1:3 and an
aliquot of the supernatant was stored for assaying re- plasmids containing wild-type and mutated env genes
were transfected into HeLa cells and the biosynthesisverse transcriptase (RT) activity. The RT assay was per-
formed as previously described (Freed and Martin, 1994). and processing of the envelope glycoproteins were ana-
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FIG. 2. Amino acid sequences of HIV-1 fusion peptide mutants. Asterisks mark residues that were targeted for mutagenesis. Residues in boxes
represent substitutions made in each construct. All the mutants were expressed in the context of the full-length env gene.
lyzed in pulse-chase metabolic labeling experiments. endoplasmic reticulum as a Mr 160,000 precursor, gp160
(Fig. 3, WT). In the late Golgi complex, the precursor isFigure 3 shows the results obtained for representative
constructs; the results for all the constructs tested are cleaved into gp120 and gp41 (Fig. 3, WT) (Freed and
Risser, 1987; McCune et al., 1988); gp41 is not apparentsummarized in Table 1.
The wild-type envelope protein is synthesized in the in the autoradiograms because it does not label very
well with [35S]methionine. As previously reported (Willey
et al., 1988), proteolytic processing of the precursor is
relatively inefficient and some gp160 can still be seen
even after 8 hr of chase (Fig. 3, WT). A fraction of the
gp120 molecules are shed into the medium from cells
expressing the wild-type construct, due to dissociation
from gp41 at the plasma membrane (Fig.3, WT) (Schnei-
der et al., 1986). For all but one (G16V) of the mutants,
the pattern of gp160 synthesis and processing, and shed-
ding of gp120, was similar to that of the wild-type glyco-
protein. Figure 3 shows the results obtained for the G10V,
G13V, and F8V constructs, which were similar to those
observed for most of the other mutants. These observa-
tions indicated that most of the mutations introduced into
the fusion peptide region of gp41 did not detectably affect
the biosynthesis and processing of the gp160 precursor
TABLE 1
Syncytium Formation Activity of Different Envelope Constructs
Normalized
gp160 gp120 Number of Envelope syncytia
Construct cleavage shedding syncytia expression (% of WT)
WT / / 516 16,890 100
G3V / / 197 18,853 34
G5V / / 772 56,016 45
G10V / / 0 6,756 0
G13V / / 50 29,399 6
G16V / /// 2 23,409 0
G20V / / 712 51,991 45
G10VG13V / / 0 16,383 0
F8V / / 430 43,588 33
F11V / / 236 51,171 15FIG. 3. Pulse-chase analysis of env gene products expressed in
transfected HeLa cells. HeLa cells expressing wild-type or mutant env
gene products were metabolically labeled with [35S]methionine and Note. Syncytium formation data are from one experiment that is rep-
resentative of several similar experiments. Syncytia were counted inchased for 0, 2, 4, or 8 hr at 377. Envelope glycoproteins were isolated
from detergent-solubilized cells and media by immunoprecipitation with 10 microscopic fields for each construct, scoring only syncytia with
greater than four nuclei. The number of syncytia was normalized fora mixture of antibodies to gp160 and gp120 (human HIV immune globu-
lin). The figure shows the results obtained for the wild-type (WT), G10V, the expression of gp160, determined by metabolic labeling, immunopre-
cipitation, and quantitation using a Phosphor Imager. The normalizedG13V, G16V, and F8V constructs. Other constructs that are not shown
in the figure gave results similar to wild type. The positions of gp160 numbers of syncytia are expressed as percentages of the wild-type
(WT) construct.and gp120 are indicated to the left of each panel.
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or the stability of association of gp120 with gp41. Since ation, was unable to induce syncytium formation (Fig. 4
and Table 1).cleavage of gp160 is thought to occur within the Golgi
complex and shedding of gp120 occurs from the plasma Although the biosynthesis and processing of the G10V
and G13V mutants were similar to those of the wild-typemembrane, these findings are consistent with a similar
rate of transport of the wild-type and mutant proteins protein (Fig. 3), suggesting that the mutant proteins were
normally transported through the secretory pathway, wethrough the secretory pathway.
The only mutant that behaved abnormally in these wanted to confirm that the failure of G10V and G13V to
induce fusion was not due to their absence from the cellassays was G16V. As shown in Fig. 3, all of the gp120
that was produced was released into the medium. This surface. To this end, we examined the surface expres-
sion of the wild-type, G10V, and G13V forms of the enve-latter characteristic indicated a decrease in the affinity
of gp120 for gp41, which could be due either to a direct lope glycoproteins by FACS analysis of transiently
transfected HeLa cells (Fig. 5). The proportion of cellsparticipation of G16 in the interaction or to a conforma-
tional effect induced by mutation of this residue. The that expressed the envelope glycoproteins on the surface
were 25% for the wild type, 20% for G10V, and 31% forG16V envelope glycoprotein may also undergo increased
degradation, since there is a significant loss of total pro- G13V (Fig. 5). The differences in the proportion of positive
cells were due to the efficiency of the transient transfec-tein during the chase (Fig. 3).
tions, as determined in parallel immunofluorescence mi-
croscopy analyses of permeabilized cells. More impor-Analysis of the fusogenic activity of different env
tantly, the mean fluorescence intensities of the surface-gene products using a syncytium formation assay
positive cells were very similar: 48 for the wild type, 42
for G10V, and 46 for G13V (Fig. 5). These experimentsHaving established that most of the mutant gene prod-
ucts had transport properties similar to the wild-type pro- demonstrated that the mutant proteins were expressed
on the cell surface at levels comparable to those of theirtein, we proceeded to test whether they could induce
membrane fusion. This was done using a syncytium for- wild-type counterpart. The small differences in surface-
expression levels are within the margin of error of thismation assay described by Felser et al. (1989). The assay
was performed by coculturing HeLa cells transiently technique and are unlikely to account for the dramatic
effects of the mutations in the syncytium formationtransfected with different pNLA1 (env) constructs with
HeLa cells stably expressing human CD4 (Maddon et al., assays. Thus, we conclude that the dramatically reduced
activity of the G10V and G13V mutants is most likely due1986). At 24 hr after coculture, monolayers were fixed
and stained with methylene blue, and the number of syn- to defects in the ability of the fusion peptide to mediate
the fusion process itself.cytia was determined by optical microscopy. The number
of syncytia observed with each construct was normalized
for the expression of envelope glycoprotein determined Infectivity of HIV-1 genomes with mutations in the
by metabolic labeling and immunoprecipitation. Repre- env gene
sentative examples of the syncytium formation assays
are shown in Fig. 4 and quantitative results for all the Several studies have suggested that the ability of HIV-
1 envelope glycoproteins to mediate cell/cell fusion, asconstructs are shown in Table 1.
Expression of a wild-type clone resulted in the appear- measured by syncytium formation assays, does not al-
ways parallel virus/cell fusion activity (Tersmette et al.,ance of numerous syncytia, each of which contained a
large number of nuclei (Fig. 4). The two glycine residues 1988; Pantaleo et al., 1991). For this reason, we decided
to assess the activity of some of our mutants in viruscontained within the sequence FLGFLG (G10 and G13)
were found to be critical for activity, since their replace- infectivity assays. To this end, mutant envelope se-
quences were subcloned into the full-length HIV-1 molec-ment by valine residues resulted in a dramatic decrease
of syncytium formation (to 0 and 6% of WT, respectively; ular clone, pNL4-3. Wild-type and mutant pNL4-3 clones
were used to transfect the CEM (12D-7) T-cell line, andFig. 4, Table 1). Mutation of other glycine residues (G3,
G5, G20) caused less dramatic reductions in activity (to RT activity in the culture supernatants was subsequently
measured every 2 days for 1 month posttransfection. A34–45% of the wild-type levels), suggesting that they
were more permissive for substitution by valine residues typical experiment is shown in Fig. 6.
The peak RT activity for the wild type clone (pNL4-3)(Table 1). Mutation of the conserved phenylalanine resi-
dues (F8 and F11) resulted in reduction of the ability to was observed at 10 days posttransfection (Fig. 6). In
contrast, transfection of G10V and G10VG13V did notform syncytia to 15–33% of the wild-type levels (Fig. 4,
Table 1). These observations implicated G10 and G13 as result in detectable RT activity even after 30 days post-
transfection (Fig. 5). Cultures transfected with the G13Vcritical elements of the fusion peptide, while other glycine
residues were less important. Residues F8 and F11 were construct produced RT activity that peaked at 16 days
posttransfection. The 6-day delay to peak RT activity rela-also important for activity, although not to the same ex-
tent as G10 and G13. Not surprisingly, the G16V mutant, tive to wild type is consistent with a drastic but incom-
plete loss of infectivity, as would be predicted from thewhich displays an apparent defect in gp120/gp41 associ-
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FIG. 4. Formation of syncytia induced by expression of wild-type and mutant pNLA1 constructs. Arrowhead points out a syncytium (in WT).
Syncytium assays were performed as described under Materials and Methods.
syncytium formation assays (Table 1). It is also possible FLGFLG that is conserved among all isolates of HIV-1
(Myers, 1988). An identical sequence is present withinthat the delayed appearance of RT activity in the G13V-
infected cells is due to the emergence of spontaneous the fusion peptide of some isolates of SIV (Table 2). In
the remaining isolates of SIV and in HIV-2, the secondrevertants, as previously shown for other mutants (Freed
and Martin, 1994). RT activity for the F8V mutant peaked glycine residue is substituted by an alanine residue (Ta-
ble 2). Substitution of an alanine for the second glycinebetween the WT and G13V clones, consistent with the
intermediate level of activity measured in the syncytium is likely to represent a conservative change, since ala-
nine has a small side chain. The inhibition of syncytiumformation assays. The G16V mutant, which displayed en-
hanced release of gp120 into the medium, was also inac- formation and virus infectivity caused by mutation of G10
or G13 to valine is most likely due to loss of activity oftive in the transfection– RT assays (Fig. 6). Thus, these
results correlated well with the observations made using the fusion peptide rather than to a gross conformational
change of the envelope glycoprotein complex inducedthe syncytium formation assay (Table 1) and confirmed
that G10 and G13 were critical for fusion. by the mutations. This conclusion is based on the fact
that the biosynthesis, processing, intracellular transport,
and surface expression of the mutant proteins are similarDISCUSSION
to those of the wild-type protein (Figs. 3 and 5). An effect
of the mutations in gp41 on binding of gp120 to CD4 isOur studies have revealed a critical role for two glycine
also unlikely since the mutant gp160 precursors bind toresidues of the HIV-1 fusion peptide (G10 and G13) in
CD4 to the same extent as the wild-type protein (datamediating syncytium formation and virus infectivity.
These residues are contained within the sequence not shown).
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FIG. 6. Infectivity of wild-type and mutant HIV-1 constructs. CEM
(12D-7) cells were transfected with pNL4-3 constructs encoding wild-
type or mutant env gene products. At 2-day intervals, culture superna-
tants were collected and assayed for reverse transcriptase (RT) activity.
(h) WT; (L) F8V; (s) G10V; ( ) G13V; (n) G10VG13V; (l) G16V. The
experiment shown in this figure is one of two experiments with similar
results.
mation. Studies of the F protein of the paramyxovirus
simian virus 5 also demonstrated that substitution of gly-
cine to alanine residues within the fusion peptide in-
creased fusogenic activity (Horvath and Lamb, 1992). In
addition to increasing hydrophobicity, placement of ala-
nine residues could also increase fusogenic activity by
stabilizing the formation of an a-helix, as previously sug-
gested (Horvath and Lamb, 1992). The above observa-
tions are all consistent with the idea that hydrophobicity
is an essential property of fusion peptides and that in-
creasing hydrophobicity is in some cases accompaniedFIG. 5. Surface expression of HIV-1 envelope glycoproteins deter-
by enhanced fusion activity. Our results suggest that, inmined by FACS analysis. HeLa cells were transfected with pNLA1
constructs encoding the wild-type envelope glycoprotein (WT) or the addition to hydrophobicity, the exact primary structure of
G10V and G13V mutants. Cells transfected with an irrelevant plasmid the fusion peptide is also important for optimal function.
(MOCK) were used as a control. At 24 hr after transfection, cells were
Indeed, all of the glycine to valine substitutions made inanalyzed for surface expression of the envelope glycoproteins by FACS,
our study increased the overall hydrophobicity as wellusing an antibody to gp120 (D19) and a fluorescein-conjugated second-
as the a-helical propensity of the fusion peptide in mem-ary antibody (see Materials and Methods). The percentage of cells
having fluorescence intensities greater than 10 units (% Pos, indicated brane environments (Li and Deber, 1994) and yet de-
by the horizontal bar) and the mean fluorescence intensity of the posi- creased the ability to induce fusion. The high degree of
tive cells (Mean) are indicated in the top right corner of each FACS
profile. The percentage of surface-positive cells is a direct reflection
of the transfection efficiency, as determined in parallel immunofluores- TABLE 2
cence microscopy experiments. The mean fluorescence intensity of the
Sequences of Viral Fusion Peptides Having Potential Glycine Stripspositive cells is a measure of the surface expression of each envelope
construct. This experiment is representative of three experiments with
Accessionsimilar results.
Virus code Sequence
HIV-1 (NL4-3) VCLJBR AVGIGALFLGFLGAAGSTMGAASPrevious mutagenesis of the region encompassing the
SIV (tyo-1) ENV_SIVAT VPFVLGFLGFLGAAGTAMGAAA
fusion peptides of HIV-1 (Freed et al., 1990) and SIV SIV (K6W) ENV_SIVMK GVFVLGFLGFLATAGSAMGAAS
(Bosch et al., 1989) showed that placement of either HIV-2 (Rod) ENV_HV2RO GVFVLGFLGFLATAGSAMGAAS
Influenza a HEMA_INAAI GLFGAIAGFIENGWEGMIDGWYGFacidic or basic amino acid residues at various places
Influenza b HEMA_INBBO GFFGAIAGFLEGGWEGMIDGWHGYwithin this region greatly decreased the ability of the
envelope to mediate syncytium formation. On the other
Note. Sequences were obtained from GenBank and EMBL data-
hand, Bosch et al. (1989) showed that substituting the bases. The variant of each virus is indicated in parentheses. Glycine
glycine residue within the FLGFLA sequence of an SIV residues with potential to form glycine strips on an a-helix (as in Fig.
1) are underlined.variant with an alanine residue enhanced syncytium for-
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conservation of the sequence of the HIV-1 fusion peptide dium. As expected, this construct was completely unable
to mediate syncytium formation and infection. The pheno-is thus likely the result of selective pressure to maintain
a particular structure that is required for fusion. The most type of this mutant is similar to that of other mutants
studied by Freed et al. (1990), who showed that mutationlikely structure that has to be preserved is that of a sided
a-helix, as previously proposed (Bosch et al., 1989; White, of A15 to E, L26 to R, or Q29 to L drastically reduced associ-
ation of gp120 with gp41 and the ability to form syncytia.1990, 1992; Blobel et al., 1992).
Within a sided a-helix, the two critical glycine residues Linker insertion mutations at M19 and L26 also disrupted
the association of gp120 and gp41 (Kowalski et al., 1987).would be found in the middle of a putative ‘‘glycine strip.’’
Other glycine residues located toward the ends of the Taken together, these observations implicate the region
of A15 to Q29 of gp41 as a potential site of contact withglycine strip or on a different face of the helix were found
to be less critical for fusion. This suggests that there is gp120.
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dues such as valine at the core of the putative glycine ACKNOWLEDGMENTS
strip, whereas the ends of the strip are more permissive
We thank Tim LaVaute for his help with the FACS analyses, Ronaldof such substitutions. In addition to primate immunodefi-
Willey and Patricia Earl for generous gifts of reagents and valuableciency viruses, influenza viruses would also be predicted
advice, and Richard Klausner, Michael Marks, and Robert Blumenthal
to have glycine-rich faces on their fusion peptides (Table for helpful discussions and critical review of the manuscript. This work
2) (White, 1990, 1992), suggesting that glycine (or more was supported by a grant from the NIH Intramural AIDS Targeted
Antiviral Program.generally glycine/alanine) strips may be a common fea-
ture of other fusion peptides.
What could be the role of glycine strips in fusion? Our REFERENCES
studies on the assembly of class II MHC molecules first
Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A.,suggested a role for glycine strips in mediating protein–
and Martin, M. A. (1986). Production of acquired immunodeficiencyprotein interactions (Cosson and Bonifacino, 1992). Ho-
syndrome-associated retrovirus in human and nonhuman cells
modimerization of glycophorin A transmembrane do- transfected with an infectious molecular clone. J. Virol. 59, 284–291.
mains has also been shown to involve contacts along a Blobel, C. P., Wolfsberg, T. G., Turck, C. W., Myles, D. G., Primakoff, P.,
and White, J. M. (1992). A potential fusion peptide and an integringlycine-rich face of hydrophobic a-helices (Lemmon et
ligand domain in a protein active in sperm–egg fusion. Nature 356,al., 1992a,b). Extending these observations to fusion pep-
248–252.tides, we speculate that glycine strips could mediate ei-
Bosch, M. L., Earl, P. L., Fargnoli, K., Picciafuoco, S., Giombini, F., Wong,
ther homotypic interactions between several fusion pep- S. F., and Franchini, G. (1989). Identification of the fusion peptide of
tides (such as formation of oligomeric structures; Guy et primate immunodeficiency viruses. Science 244, 694–697.
Brasseur, R., Lorge, P., Goormaghtigh, E., Ruysschaert, J. M., Espion,al., 1992) or heterotypic interactions with host cell factors
D., and Burny, A. (1988). The mode of insertion of the paramyxovirus(such as binding to a putative second receptor; Hender-
F1 N-terminus into lipid matrix, an initial step in host cell/virus fusion.son and Qureshi, 1993). Oligomerization of fusion pep-
Virus Genes 1, 325–332.
tides may participate in the mechanism of formation of Broder, C. C., Dimitrov, D. S., Blumenthal, R., and Berger, E. A. (1993).
a ‘‘fusion pore’’ that would then expand and allow entry The block to HIV-1 envelope glycoprotein-mediated membrane fu-
sion in animal cells expressing human CD4 can be overcome by aof the virus into the cell (White, 1990, 1992). Additional
human cell component(s). Virology 193, 483–491.support for homotypic interactions comes from experi-
Cosson, P., and Bonifacino, J. S. (1992). Role of transmembrane domainments with a transdominant mutant fusion peptide that
interactions in the assembly of class II MHC molecules. Science
suggest that there is cooperativity in the function of the 258, 659–662.
fusion peptide (Freed et al., 1992). An alternative explana- Dalgleish, A. G., Beverley, P. C., Clapham, P. R., Crawford, D. H.,
Greaves, M. F., and Weiss, R. A. (1984). The CD4 (T4) antigen is antion would be that the glycine residues provide the right
essential component of the receptor for the AIDS retrovirus. Naturebalance of amphipathicity or sidedness necessary for
312, 763–767.merging of the viral and host cell membranes, as has
Earl, P. L., Broder, C. C., Long, D., Lee, S. A., Peterson, J., Chakrabarti,
been postulated for influenza virus (White, 1992). Finally, S., Doms, R. W., and Moss, B. (1994). Native oligomeric human immu-
conservation of the glycine residues may be important nodeficiency virus type 1 envelope glycoprotein elicits diverse mono-
clonal antibody reactivities. J. Virol. 68, 3015–3026.for oblique insertion of the fusion peptide into the target
Epand, R. M., Cheetham, J. J., Epand, R. F., Yeagle, P. L., Richardson,membrane, as suggested by studies of SIV (Horth et al.,
C. D., Rockwell, A., and Degrado, W. F. (1992). Peptide models for1991). A distinction between these possible explanations
the membrane destabilizing actions of viral fusion proteins. Biopoly-
will have to await a more detailed characterization of the mers 32, 309–314.
physicochemical properties of fusion peptides, as well Felser, J. M., Klimkait, T., and Silver, J. (1989). A syncytia assay for
human immunodeficiency virus type I (HIV-I) envelope protein andas a better understanding of the fusion process itself.
its use in studying HIV-I mutations. Virology 170, 566–570.While most of the mutations examined in this study
Freed, E. O., Delwart, E. L., Buchschacher, G. L., Panganiban, J., anddid not affect properties of the envelope glycoprotein
Panganiban, A. J. (1992). A mutation in the human immunodeficiency
other than the ability to induce syncytium formation, mu- type I transmembrane glycoprotein 41 dominantly interferes with
tation of G16 to V had a qualitatively different effect. This fusion and infectivity. Proc. Natl. Acad. Sci. USA 89, 70–74.
Freed, E. O., and Martin, M. A. (1994). Evidence for a functional interac-mutation enhanced the release of gp120 into the me-
AID VY 7797 / 6a13$$$161 03-01-96 01:10:01 viral AP: Virology
102 DELAHUNTY ET AL.
tion between the V1/V2 and C4 domains of human immunodeficiency receptor and is expressed in the immune system and the brain. Cell
47, 333–348.virus type 1 envelope glycoprotein gp120. J. Virol. 68, 2503–2512.
Freed, E. O., and Martin, M. A. (1995). The role of human immunodefi- Martin, I., Defrise, Q. F., Mandieau, V., Nielsen, N. M., Saermark, T.,
Burny, A., Brasseur, R., Ruysschaert, J. M., and Vandenbranden, M.ciency virus type 1 envelope glycoproteins in virus infection. J. Biol.
Chem. 270, 23883–23886. (1991). Fusogenic activity of SIV (simian immunodeficiency virus)
peptides located in the GP32 NH2 terminal domain. Biochem. Bio-Freed, E. O., Myers, D. J., and Risser, R. (1989). Mutational analysis of
the cleavage sequence of the human immunodeficiency virus type phys. Res. Commun. 175, 872–879.
McCune, J. M., Rabin, L. B., Feinberg, M. B., Lieberman, M., Kosek,I envelope protein precursor gp160. J. Virol. 63, 4670–4675.
Freed, E. O., Myers, D. J., and Risser, R. (1990). Characterization of the J. C., Reyes, G. R., and Weissman, I. L. (1988). Endoproteolytic cleav-
age of gp160 is required for the activation of human immunodefi-fusion domain of the human immunodeficiency virus type 1 envelope
glycoprotein gp41. Proc. Natl. Acad. Sci. USA 87, 4650–4654. ciency virus. Cell 53, 55–67.
Myers, G. (1988). In ‘‘Human Retroviruses and AIDS 1988’’ (G. MyersFreed, E. O., and Risser, R. (1987). The role of envelope glycoprotein
processing in murine leukemia virus infection. J. Virol. 61, 2852– et al., Eds.), p. 68.
Nieva, J. L., Nir, S., Muga, A., Gon˜i, F. M., and Wilschut, J. (1994).2856.
Gallaher, W. R. (1987). Detection of a fusion peptide sequence in the Interaction of the HIV-1 fusion peptide with phospholipid vesicles:
Different structural requirements for fusion and leakage. Biochemis-transmembrane protein of human immunodeficiency virus. Cell 50,
327–328. try 33, 3201–3209.
Pantaleo, G., Poli, G., Butini, L., Fox, C., Dayton, A. I., and Fauci, A. S.Gallaher, W. R., Segrest, J. P., and Hunter, E. (1992). Are fusion peptides
really sided insertional helices? Cell 70, 531–532. (1991). Dissociation between syncytia formation and HIV spreading.
Suppression of syncytia formation does not necessarily reflect inhibi-Graham, F. L., and van der Eb, A. J. (1973). A new technique for the
assay of infectivity of human adenovirus 5 DNA. Virology 52, 456– tion of HIV infection. Eur. J. Immunol. 21, 1771–1774.
Rafalski, M., Lear, J. D., and Degrado, W. F. (1990). Phospholipid interac-467.
Guy, H. R., Durell, S. R., Schoch, C., and Blumenthal, R. (1992). Analyzing tions of synthetic peptides representing the N-terminus of HIV gp41.
Biochemistry 29, 7917–7922.the fusion process of influenza hemagglutinin by mutagenesis and
molecular modeling. Biophys. J. 62, 95–97. Rusche, J. R., Javaherian, K., McDanal, C., Petro, J., Lynn, D. L., Grimaila,
R., Langlois, A., Gallo, R. C., Arthur, L. O., Fischinger, P. J., Bolognesi,Henderson, L. A., and Qureshi, M. N. (1993). A peptide inhibitor of
human immunodeficiency virus infection binds to novel human cell D. P., Putney, S. D., and Matthews, T. J. (1988). Antibodies that inhibit
fusion of human immunodeficiency virus-infected cells bind a 24-surface polypeptides. J. Biol. Chem. 268, 15291–15297.
Horth, M., Lambrecht, B., Khim, M. C. L., Bex, F., Thiriart, C., Ruysschaert, amino acid sequence of the viral envelope, gp120. Proc. Natl. Acad.
Sci. USA 85, 3198–3202.J. M., Burny, A., and Brasseur, R. (1991). Theoretical and functional
analysis of the SIV fusion peptide. EMBO J. 10, 2747–2755. Schneider, J., Kaaden, O., Copeland, T. D., Oroszlan, S., and Hunsmann,
G. (1986). Shedding and interspecies type sero-reactivity of the enve-Horvath, C. M., and Lamb, R. A. (1992). Studies on the fusion peptide
of a paramyxovirus fusion glycoprotein: Roles of conserved residues lope glycoprotein gp120 of the human immunodeficiency virus. J.
Gen. Virol. 67, 2533–2538.in cell fusion J. Virol. 66, 2443 –2455.
Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Sodroski, J., Goh, W. C., Rosen, C., Campbell, K., and Haseltine, W. A.
(1986). Role of the HTLV-III/LAV envelope in syncytium formation andHercend, T., Gluckman, J. C., and Montagnier, L. (1984). T-lymphocyte
T4 molecule behaves as the receptor for human retrovirus LAV. Na- cytopathicity. Nature 322, 470–474.
Stein, B. S., Gowda, S. D., Lifson, J. D., Penhallow, R. C., Bensch, K. G.,ture 312, 767–768.
Kowalski, M., Potz, J., Basiripour, L., Dorfman, T., Goh, W. C., Terwilliger, and Engleman, E. G. (1987). pH-independent HIV entry into CD4-
positive T cells via virus envelope fusion to the plasma membrane.E., Dayton, A., Rosen, C., Haseltine, W., and Sodroski, J. (1987). Func-
tional regions of the envelope glycoprotein of human immunodefi- Cell 49, 659–668.
Sullivan, N., Thali, M., Furman, C., Ho, D. D., and Sodroski, J. (1993).ciency virus type 1. Science 237, 1351–1355.
Lasky, L. A., Nakamura, G., Smith, J. H., Fennie, C., Shimosaki, L., Patzer, Effect of amino acid changes in the V1/V2 region of the human
immunodeficiency virus type I gp120 glycoprotein on subunit associ-E., Berman, P., Gregory, T., and Capon, D. J. (1987). Delineation of a
region of the human immunodeficiency virus type 1 (HIV-1) gp120 ation, syncytium formation, and recognition by a neutralizing anti-
body. J. Virol. 67, 3674–3679.glycoprotein critical for interaction with the CD4 receptor. Cell 50,
975–985. Tersmette, M., De Goede, G. R., Al, B. J., Winkel, I. N., Gruters, R. A.,
Cuypers, H. T., Huisman, H. G., and Miedema, F. (1988). DifferentialLemmon, M. A., Flanagan, J. M., Hunt, J. F., Adair, B. D., Bormann,
B. J., Dempsey, C. E., and Engelman, D. M. (1992a). Glycophorin A syncytium-inducing capacity of human immunodeficiency virus iso-
lates: Frequent detection of syncytium-inducing isolates in patientsdimerization is driven by specific interactions between transmem-
brane alpha-helices. J. Biol. Chem. 267, 7683–7689. with acquired immunodeficiency syndrome (AIDS) and AIDS-related
complex. J. Virol. 62, 2026–2032.Lemmon, M. A., Flanagan, J. M., Treutlein, H. R., Zhang, J., and Engel-
man, D. M. (1992b). Sequence specificity in the dimerization of trans- White, J. M. (1990). Viral and cellular membrane fusion proteins. Annu.
Rev. Physiol. 52, 675–697.membrane alpha-helices. Biochemistry 31, 12719–12725.
Li, S. C., and Deber, C. M. (1994). A measure of helical propensity for White, J. M. (1992). Membrane fusion. Science 258, 917–924.
Willey, R. L., Bonifacino, J. S., Potts, B. J., Martin, M. A., and Klausner,amino acids in membrane environments. Struct. Biol. 1, 368–373.
Lifson, J. D., Feinberg, M. B., Reyes, G. R., Rabin, L., Banapour, B., R. D. (1988). Biosynthesis, cleavage, and degradation of the human
immunodeficiency virus 1 envelope glycoprotein gp160. Proc. Natl.Chakrabarti, S., Moss, B., Wong-Staal, F., Steimer, K. S., and Engle-
man, E. G. (1986). Induction of CD4-dependent cell fusion by the Acad. Sci. USA 85, 9580–9584.
Willey, R. L., Maldarelli, F., Martin, M. A., and Strebel, K. (1992). HumanHTLV-III/LAV envelope glycoprotein. Nature 323, 725–728.
Maddon, P. J., Dagleish, A. G., McDougal, J. S., Clapman, P. R., Weiss, Immunodeficiency virus type I vpu protein regulates the formation
of intracellular gp160–CD4 complexes. J. Virol. 66, 226–234.R. A., and Axel, R. (1986). The T4 gene encodes the AIDS virus
AID VY 7797 / 6a13$$$161 03-01-96 01:10:01 viral AP: Virology
